Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 1/20 | 0.46 |
| ▸ | ARG1 | P05089 | 1/20 | 0.46 |
| ▸ | ARG2 | P78540 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 3/20 | 0.45 |
| ▸ | NOS1 | P29475 | 2/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | KIF11 | P52732 | 6/20 | 0.40 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.40 |
| ▸ | BHMT | Q93088 | 2/20 | 0.38 |
| ▸ | GFPT1 | Q06210 | 1/20 | 0.38 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3685144 | 1.00 | SLC1A1 (0.46) | SLC1A1ARG1ARG2NOS2NOS1 | |
| SCHEMBL3632964 | 0.85 | KIF11 (0.41) | SLC1A1KIF11 | |
| SCHEMBL28589135 | 0.83 | ARG1 (0.53) | SLC1A1ARG1ARG2NOS2NOS1 | |
| SCHEMBL28589137 | 0.83 | ARG1 (0.53) | SLC1A1ARG1ARG2NOS2NOS1 | |
| Hydrochloric Acid SCHEMBL10770246 | 0.83 | KIF11 (0.40) | SLC1A1KIF11 | |
| Hydrochloric Acid SCHEMBL11196457 | 0.83 | KIF11 (0.40) | SLC1A1KIF11 | |
| SCHEMBL27653685 | 0.83 | GSR (0.49) | SLC1A1ARG1ARG2NOS2NOS1 | |
| SCHEMBL10796639 | 0.81 | CYP1A2 (0.46) | SLC1A1ARG1ARG2NOS2NOS1 | |
| SCHEMBL30983358 | 0.80 | ARG1 (0.42) | ARG1ARG2NOS2NOS1NOS3 | |
| SCHEMBL7363488 | 0.80 | ARG1 (0.42) | ARG1ARG2NOS2NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021093733-A1 | QUALITY CONTROL METHOD FOR CARBOCISTEINE RAW MATERIAL AND FORMULATION THEREOF, AND USE THEREOF | 广东华南药业集团有限公司 | 2021-05-20 | — | — | WO | disclosed |
| US-8703750-B2 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2014-04-22 | — | — | US | disclosed |
| CN-1925748-B | Mixtures and methods for inducing resistance in plants | ISAGRO SPA | 2011-08-10 | — | — | CN | disclosed |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2010-12-16 | — | — | US | disclosed |
| US-20070173459-A1 | Mixtures and methods for the induction of resistance in plants | ISAGRO S.P.A. (IT) | 2007-07-26 | — | — | US | disclosed |
| CN-1925748-A | Mixtures and methods for inducing resistance in plants | ISAGRO SPA (IT) | 2007-03-07 | — | — | CN | disclosed |
| EP-1720408-A1 | MIXTURES AND METHODS FOR THE INDUCTION OF RESISTANCE IN PLANTS | ISAGRO S.p.A. (IT) | 2006-11-15 | — | — | EP | disclosed |
| WO-2005094580-A1 | MIXTURES AND METHODS FOR THE INDUCTION OF RESISTANCE IN PLANTS | ISAGRO S.P.A. (IT) | 2005-10-13 | — | — | WO | disclosed |
| EP-0765340-B1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INT INC (US) | 2000-08-30 | — | — | EP | disclosed |
| US-5776927-A | THROMBIN INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5770600-A | Methionine sulfone and S-substituted cysteine sulfone derivatives as enzyme inhibitors | CORVAS INTERNATIONAL, INC. (US) | 1998-06-23 | — | — | US | disclosed |
| US-5681844-A | ANTITHROMBOTIC AGENTS, ANTICOAGULANTS | CORVAS INTERNATIONAL, INC. (US) | 1997-10-28 | — | — | US | disclosed |
| US-5658939-A | PREVENTION THROMBOSIS IN MAMMALS | CORVAS INTERNATIONAL INC. (US) | 1997-08-19 | — | — | US | disclosed |
| US-5646165-A | ANTITHROMBOTIC AGENTS | CORVAS INTERNATIONAL, INC. (US) | 1997-07-08 | — | — | US | disclosed |
| EP-0765340-A1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1997-04-02 | — | — | EP | disclosed |
| WO-1995028420-A1 | METHIONINE SULFONE AND S-SUBSTITUTED CYSTEINE SULFONE DERIVATIVES AS ENZYME INHIBITORS | CORVAS INTERNATIONAL, INC. (US) | 1995-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070173459-A1 | Mixtures and methods for the induction of resistance in plants | SLC11A2, MYD88, ME2 | SLC1A1 3453/4885ARG1 1216/4885ARG2 1038/4885 |
| US-20100317519-A1 | Mixtures and methods for the induction of resistance in plants | SLC11A2, MYD88, ME2 | SLC1A1 3453/4885ARG1 1216/4885ARG2 1038/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.